Immunome to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Rhea-AI Summary

Immunome, Inc. (IMNM) will present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on February 8. The company focuses on developing targeted cancer therapies and invites interested parties to access the live audio webcast from their website.

BOTHELL, Wash.--(BUSINESS WIRE)-- Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that members of Immunome management will present at the Guggenheim Healthcare Talks 6^th Annual Biotechnology Conference on Thursday, February 8 at 9:30 a.m. ET.

Interested parties can access the live audio webcast for this conference from the Investor Relations section of the company’s website at www.immunome.com. The webcast replay will be available after the conclusion of the live presentation for approximately 30 days.

About Immunome, Inc.

Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies. Our portfolio pursues each target with a modality appropriate to its biology, including radioligand therapies, ADCs, and immunotherapies. We believe that pursuing underexplored targets with appropriate drug modalities leads to transformative therapies. Our proprietary memory B cell hybridoma technology allows for the rapid screening and functional characterization of novel antibodies and targets.

For more information, visit www.immunome.com or follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240205221785/en/

Max Rosett

Interim Chief Financial Officer

investors@immunome.com

Source: Immunome, Inc.

FAQ

When will Immunome, Inc. present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference?

Immunome, Inc. will present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8 at 9:30 a.m. ET.

What is the focus of Immunome, Inc.?

Immunome, Inc. focuses on developing first-in-class and best-in-class targeted cancer therapies.

Where can interested parties access the live audio webcast for the conference?

Interested parties can access the live audio webcast for the conference from the Investor Relations section of the company’s website at www.immunome.com.

How long will the webcast replay be available?

The webcast replay will be available after the conclusion of the live presentation for approximately 30 days.